Thrombocytopenia in hospitalized patients receiving heparin

---be it low molecular weight or unfractionated heparin, in systemic anticoagulant doses, is common (36.4% of patients in the CATCH registry) and associated with increased mortality despite the fact that heparin induced thrombocytopenia (HIT) was not suspected or proven in the vast majority of patients.